Top BB M&A vs. EB RX
Hi all,
Just wanted perspective on M&A vs RX going into the incoming recession.
I go to a target with strong contacts at top BBs (MS M&A) and also strong RX contacts (PJT, HL, Laz). For some EBs, I have to choose between the two groups as the processes are mutually exclusive. I understand that there are distinct differences on the job, and that comes down to a personal decision, but objective I would like to inquire about the exit opportunities?
I see people go from regional coverage groups at BBs go on to top distressed PE/HF, so is it entirely necessary to go the RX route at an EB, where I know I will be crushed in the next few years? How would you guys compare a top BB in a top group (GS/MS/JPM) vs. RX at a top EB if I want to exit to a top PE or HF fund in the future and for BSchool placements?
Thanks in advance.
I think M&A & Rx analyst programs would be really interesting (Moelis, Greenhill, etc)
Greenhill no longer combines the two, they’re split now
Deleted
PJT too
PJT splits analysts into M&A and RSSG
Personally, I don't think you should be making your decision on the likelihood of a recession. Exit opps are going to be available to you regardless of the either choice you make for the top PEs, except for a few "weaker" or "less relevant" groups at the top BBs. You shouldn't be grouping top PE & HF exit opps into a single bucket, as each attracts different applicants. For top HFs, I've seen more direct exits from RX and M&A groups at EBs (particularly from PJT and Evercore).
There are also further distinctions even within the "top" BB groups vs "top" EB RX/M&A groups. For ex, many would be choosing Evercore's RX over JPM while many would be opting for GS over Laz's RX. At my target (H/S/W), candidates' priority usually is Evercore/PJT/GS then MS, then JPM (among your listed banks). But remember that many top top candidates place directly into mega PE funds and decent HFs as well.
As for BSchool, it really doesn't matter. It's more about what you make out of the experience, exits, undergrad name, background, and how you differentiate yourself among the finance circle.
agree with above poster. important notes to consider are culture and compensation, which at a high level (although each EB is different in this regard) favors the EBs, esp. for compensation. As for M&A vs RX, RX kids will get looks from the start PE and HF firms but also distressed shops, while M&A kids mostly don't exit to distressed.
however I think it's valid to consider the macro backdrop, esp because there's a lot of uncertainty regarding the economic future of the virus. RX work is already picking up and the lifestyle changes are showing, whereas at least in the short-term, M&A activity (and corresponding bonuses) will drop. but if you're still 2 years out from actually working this'll be less of an issue
Agreed. Even without considering the macro circumstances, I'd value RX at top EB more highly than M&A at top BB.
How hard is it to lateral to RX if you're coming from a group such as M&A, LevFin, or coverage groups like consumer/retail or industrials?
Honestly I think most people would take also LAZ RX over JPM, think who's technical enough to get LAZ RX would not enjoy as much JPM experience
Deleted
Officia aut inventore sed odio facere nihil voluptatum. Impedit minus dicta nostrum doloremque possimus nisi placeat et. Ex at porro fugit dolor ipsam. Qui sit blanditiis error explicabo. Iste ipsam consequatur ad debitis qui quis doloribus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...